People: Entera Bio Ltd (ENTX.OQ)
20 Nov 2019
Dr. Hillel Galitzer is Chief Operating Officer of the company since February 2014, and prior to that served as our Director of Scientific Development from July 2012. Between August 2010 and February 2014, Dr. Galitzer was an analyst and the chief operating officer for Hadasit Bio Holdings Ltd., a publicly traded company on the Tel Aviv Stock Exchange and OTC markets. He has more than 10 years of experience in medical research and molecular biology. He is the co-founder and former chief operating officer of Optivasive Inc. He has written numerous publications in peer-reviewed journals and has lectured and presented in international conferences and universities. Dr. Galitzer received his Ph.D. from the Hebrew University Medical School in Jerusalem, where he was mentored by two world renowned researchers in the areas of parathyroid hormone and calcium regulation, his M.B.A. from Bar Ilan University in Israel and his B.Med.Sc. from the Hebrew University Medical School in Jerusalem.
|Total Annual Compensation, USD||257,993|
|Restricted Stock Award, USD||58,311|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||24,808|
|Fiscal Year Total, USD||341,112|